Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: Poland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20102
20114
20121
20131
20142
20171
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Novartis Pharmaceuticals3
AstraZeneca1
Faes Farma, S.A.1
Hoffmann-La Roche1
Incyte Corporation1
Janssen Research & Development, LLC1
Pharmacyclics LLC.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome15
Lymphoma, Follicular5
Leukemia4
Psoriasis4
Leukemia, Lymphocytic, Chronic, B-Cell3
Pruritus3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Arthralgia1
Arthritis, Juvenile1
Bone Marrow Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.